Cargando…
Type 2 Diabetes Mellitus Management and Body Mass Index: Experiences with Initiating Insulin Detemir in the A(1)chieve Study
INTRODUCTION: This sub-analysis of the A(1)chieve study aimed to examine the safety and efficacy of insulin detemir (IDet) initiation over 24 weeks in relation to baseline body mass index (BMI) in people with type 2 diabetes mellitus (T2DM). METHODS: A(1)chieve was a 24-week non-interventional study...
Autores principales: | Khamseh, Mohammed E., Prusty, Vinay, Latif, Zafar, Gonzalez-Galvez, Guillermo, Dieuzeide, Guillermo, Zilov, Alexey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065301/ https://www.ncbi.nlm.nih.gov/pubmed/24477670 http://dx.doi.org/10.1007/s13300-014-0054-2 |
Ejemplares similares
-
Safety and Effectiveness of Insulin Detemir in Different Age-Groups in the A(1)chieve Study
por: Malek, Rachid, et al.
Publicado: (2013) -
Safety and Effectiveness of Biphasic Insulin Aspart 30 in Different Age-Groups: A(1)chieve Sub-Analysis
por: Khamseh, Mohammad Ebrahim, et al.
Publicado: (2013) -
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the East India cohort of the A(1)chieve study
por: Sahoo, Abhay Kumar, et al.
Publicado: (2013) -
Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A(1)chieve study
por: Litwak, Leon, et al.
Publicado: (2013) -
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Agadir cohort of the A(1)chieve study
por: Boussouf, Hicham, et al.
Publicado: (2013)